Nippon India Pharma Fund Direct Bonus
Summary Info
Fund Name
: Nippon India Mutual Fund
Scheme Name
: Nippon India Pharma Fund Direct Bonus
AMC
: Nippon India Mutual Fund
Type
: Open
Category
: Equity - Pharma
Launch Date
: 01-Jan-2013
Fund Manager
: Sailesh Raj Bhan
Net Assets (Rs. cr)
: 8113.59
Nippon India Pharma Fund Direct Bonus - Nav Details
Nav Date
: 29-Oct-2025
NAV [Rs.]
: 576.1215
Buy/Resale Price [Rs.]
: 0
Sell/Repurchase Price [Rs.]
: 0
Entry Load %
:
Exit Load %
:
Nippon India Pharma Fund Direct Bonus- NAV Chart
Nippon India Pharma Fund Direct Bonus- Performance(%)
Returns above 1 yr. are annualized
1W | 1M | 3M | 6M | 1Y | 3Y | 5Y | Since INC | |
|---|---|---|---|---|---|---|---|---|
| Scheme Returns | -0.17 | 3.73 | -3.44 | 4.36 | 2.62 | 22.68 | 19.55 | 17.82 |
| Category Avg | -0.88 | 3.29 | -1.26 | 5.35 | 2.38 | 23.1 | 18.51 | 16.03 |
| Category Best | -0.03 | 4.94 | 1.33 | 9.55 | 11.68 | 28.55 | 21.74 | 31.72 |
| Category Worst | -1.36 | 2.16 | -3.3 | 2.31 | -4.23 | 19.55 | 14.28 | -2.75 |
Nippon India Pharma Fund Direct Bonus- Latest Dividends
No Records Found
Nippon India Pharma Fund Direct Bonus- Investment Details
Min. Investment(Rs.)
: 5000
Increm.Investment(Rs.)
: 1000
In & Out
In
InName Of The CompanyNo Of Shares
--
Out
InName Of The CompanyNo Of Shares
--
Fund Holdings
Asset Type | Instrument Name | Industry | Net Assets(%) | No of Shares | Mkt Value(Cr.) |
|---|---|---|---|---|---|
| Equity & Equity related Investments | |||||
| Equity | Sun Pharma.Inds. | Pharmaceuticals & Biotechnology | 12.29 | 6256349 | 997.44 |
| Equity | Lupin | Pharmaceuticals & Biotechnology | 7.26 | 3083991 | 589.44 |
| Equity | Divi's Lab. | Pharmaceuticals & Biotechnology | 7.01 | 1000031 | 568.96 |
| Equity | Cipla | Pharmaceuticals & Biotechnology | 6.48 | 3495054 | 525.41 |
| Equity | Apollo Hospitals | Healthcare Services | 5.92 | 648795 | 480.69 |
| Equity | Dr Reddy's Labs | Pharmaceuticals & Biotechnology | 5.91 | 3916074 | 479.21 |
| Equity | Vijaya Diagnost. | Healthcare Services | 3.56 | 2886684 | 288.66 |
| Equity | Medplus Health | Retailing | 3.39 | 3627277 | 274.74 |
| Equity | Gland Pharma | Pharmaceuticals & Biotechnology | 3.24 | 1320549 | 263.00 |
| Equity | Glaxosmi. Pharma | Pharmaceuticals & Biotechnology | 2.99 | 913226 | 242.89 |
| Equity | Ajanta Pharma | Pharmaceuticals & Biotechnology | 2.85 | 959323 | 230.84 |
| Equity | Sai Life | Pharmaceuticals & Biotechnology | 2.71 | 2555745 | 219.97 |
| Equity | Abbott India | Pharmaceuticals & Biotechnology | 2.48 | 68677 | 201.15 |
| Equity | Dr Lal Pathlabs | Healthcare Services | 2.34 | 609112 | 189.92 |
| Equity | Aurobindo Pharma | Pharmaceuticals & Biotechnology | 2.27 | 1702630 | 184.54 |
| Equity | Mankind Pharma | Pharmaceuticals & Biotechnology | 2.27 | 757496 | 184.50 |
| Equity | Thyrocare Tech. | Healthcare Services | 2.25 | 1572828 | 182.54 |
| Equity | Narayana Hrudaya | Healthcare Services | 2.20 | 1029215 | 178.83 |
| Equity | Alkem Lab | Pharmaceuticals & Biotechnology | 2.16 | 323678 | 175.59 |
| Equity | J B Chemicals & | Pharmaceuticals & Biotechnology | 2.11 | 999649 | 170.91 |
| Equity | Biocon | Pharmaceuticals & Biotechnology | 1.98 | 4719374 | 160.93 |
| Equity | Pfizer | Pharmaceuticals & Biotechnology | 1.98 | 318249 | 160.27 |
| Equity | Suraksha Diagno. | Healthcare Services | 1.43 | 3896349 | 116.24 |
| Equity | Ipca Labs. | Pharmaceuticals & Biotechnology | 1.35 | 820020 | 109.80 |
| Equity | Torrent Pharma. | Pharmaceuticals & Biotechnology | 1.35 | 303364 | 109.30 |
| Equity | Sanofi India | Pharmaceuticals & Biotechnology | 1.32 | 230272 | 107.07 |
| Equity | Fortis Health. | Healthcare Services | 1.32 | 1103889 | 107.05 |
| Equity | Sanofi Consumer | Pharmaceuticals & Biotechnology | 1.24 | 213659 | 100.85 |
| Equity | Anthem Bioscienc | Pharmaceuticals & Biotechnology | 0.99 | 1058503 | 80.57 |
| Equity | Syngene Intl. | Healthcare Services | 0.98 | 1280492 | 79.75 |
| Equity | Akums Drugs | Pharmaceuticals & Biotechnology | 0.82 | 1515264 | 66.89 |
| Equity | Emcure Pharma | Pharmaceuticals & Biotechnology | 0.74 | 470272 | 60.19 |
| Equity | Astrazeneca Phar | Pharmaceuticals & Biotechnology | 0.70 | 62568 | 56.97 |
| Equity | Indoco Remedies | Pharmaceuticals & Biotechnology | 0.66 | 1834924 | 53.57 |
| Equity | Orchid Pharma | Pharmaceuticals & Biotechnology | 0.43 | 492727 | 34.58 |
| Equity | Zydus Lifesci. | Pharmaceuticals & Biotechnology | 0.23 | 194016 | 19.05 |
| Equity | Concord Biotech | Pharmaceuticals & Biotechnology | 0.23 | 111738 | 18.41 |
| Cash & Cash Equivalent | |||||
| Reverse Repo | TREPS | -/- | 0.46 | 0 | 37.51 |
| Net CA & Others | Net CA & Others | -/- | 0.10 | 0 | 4.99 |
| Cash & Cash Equivalent | C C I | -/- | 0.00 | 0 | 0.21 |
MY WEALTH AT RETIREMENT
Calculate the worth of your wealth at retirement
Key information
Fund House:
Nippon India Mutual Fund
Incorporation Date:
24-Feb-1995
Total Assets Managed (Cr.):
6,63,683.95
Trustee/s:
Mr. A N Shanbhag - Associ, Nippon Life India Trustee
Chairman:
NA
CEO / MD:
Mr. Sundeep Sikka
CIO:
NA
President:
NA
Director/s:
Mr. Akira Shibata, Mr. Sushil C. Tripathi, Mr. Kazuhide Toda, Mr. Takayuki Murai
Compliance Officer/s:
Mr. Muneesh Sud
Investor Service Officer/s:
Mr. Milind Nesarikar
Fund Manager/s:
Sailesh Raj Bhan
Auditors:
Haribhakti & Co LLP Chart
OTHER INFORMATION
Registered Office:
4th Floor, Tower A, Peninsula Busines -s Park, Ganapatrao Kadam Marg Lower Parel (W), Mumbai - 400013.
Contact Nos:
022-68087000/1860260111
Fax:
022-68087097
Website:
